Ignite Creation Date:
2025-12-24 @ 7:40 PM
Ignite Modification Date:
2026-05-15 @ 9:02 PM
Study NCT ID:
NCT05184803
Status:
RECRUITING
Last Update Posted:
2024-02-28
First Post:
2021-12-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 2 Study of Neoadjuvant Docetaxel, Oxaliplatin, S-1 in Patients With Unresectable Locally Advanced or Distant Metastasis Limited to Lymph Node Gastric Cancer
Sponsor:
Asan Medical Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Stomach Neoplasm | View |